ArticlePloS one2025
Assessment of medication review among pharmacy professionals in the UAE: A cross-sectional study on knowledge, attitudes, practices, and barriers.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedication reviews are vital for optimizing patient care and resolving drug-related problems, with pharmacists playing a key role. Understanding pharmacists' knowledge, attitudes, perceived barriers, and practices regarding medication reviews in the UAE is crucial for enhancing medication safety.
aimTo assess the knowledge, attitudes, perceived barriers, and practices of pharmacy professionals in the UAE concerning medication reviews.
methodsAn online cross-sectional survey was distributed to licensed pharmacists in the UAE with at least a bachelor's degree. The survey collected data on demographics, knowledge, attitudes, perceived barriers, and practices related to medication reviews. Descriptive statistics, Mann-Whitney U tests, Kruskal-Wallis H tests, and Spearman's rank correlation were used for data analysis.
resultsOf 426 pharmacists approached, 421 responded (98.8%). Most agreed that medication reviews should be pharmacist-led (99.5%) and include comprehensive patient profiles (99.0%). Awareness was high for prescription reviews (94.3%) but low for Pharmaceutical Care Network Europe classifications (4.3%). Positive attitudes were widespread (98.8%), and major barriers included time constraints (83.6%) and workload (76.7%). Around 73% conducted medication reviews, but over half did not use standardized tools. Gender differences were found in knowledge (p = 0.003) and attitudes (p = 0.007).
conclusionPharmacists in the UAE have positive attitudes toward medication reviews but face barriers, particularly time constraints and workload. Enhanced training is needed to address these issues and improve patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.